Authors:
Pittet, MJ
Speiser, DE
Valmori, D
Rimoldi, D
Lienard, D
Lejeune, F
Cerottini, JC
Romero, P
Citation: Mj. Pittet et al., Ex vivo analysis of tumor antigen specific CD8(+) T cell responses using MHC/peptide tetramers in cancer patients, INT IMMUNO, 1(7), 2001, pp. 1235-1247
Authors:
Romero, P
Dutoit, V
Rubio-Godoy, V
Lienard, D
Speiser, D
Guillaume, P
Servis, K
Rimoldi, D
Cerottini, JC
Valmori, D
Citation: P. Romero et al., CD8(+) T-cell response to NY-ESO-1: Relative antigenicity and in vitro immunogenicity of natural and analogue sequences, CLIN CANC R, 7(3), 2001, pp. 766S-772S
Authors:
Pittet, MJ
Speiser, DE
Lienard, D
Valmori, D
Guillaume, P
Dutoit, V
Rimoldi, D
Lejeune, F
Cerottini, JC
Romero, P
Citation: Mj. Pittet et al., Expansion and functional maturation of human tumor antigen-specific CD8(+)T cells after vaccination with antigenic peptide, CLIN CANC R, 7(3), 2001, pp. 796S-803S
Authors:
Rubio-Godoy, V
Dutoit, V
Rimoldi, D
Lienard, D
Lejeune, F
Speiser, D
Guillaume, P
Cerottini, JC
Romero, P
Valmori, D
Citation: V. Rubio-godoy et al., Discrepancy between ELISPOT IFN-gamma secretion and binding of A2/peptide multimers to TCR reveals interclonal dissociation of CTL effector function from TCR-peptide/MHC complexes half-life, P NAS US, 98(18), 2001, pp. 10302-10307
Authors:
Sliz, P
Michielin, O
Cerottini, JC
Luescher, I
Romero, P
Karplus, M
Wiley, DC
Citation: P. Sliz et al., Crystal structures of two closely related but antigenically distinct HLA-A2/Melanocyte-Melanoma tumor-antigen peptide complexes, J IMMUNOL, 167(6), 2001, pp. 3276-3284
Authors:
Speiser, DE
Colonna, M
Ayyoub, M
Cella, M
Pittet, MJ
Batard, P
Valmori, D
Guillaume, P
Lienard, D
Cerottini, JC
Romero, P
Citation: De. Speiser et al., The activatory receptor 2B4 is expressed in vivo by human CD8(+) effector alpha beta T cells, J IMMUNOL, 167(11), 2001, pp. 6165-6170
Authors:
Blanchet, JS
Valmori, D
Dufau, I
Ayyoub, M
Nguyen, C
Guillaume, P
Monsarrat, B
Cerottini, JC
Romero, P
Gairin, JE
Citation: Js. Blanchet et al., A new generation of Melan-A/MART-1 peptides that fulfill both increased immunogenicity and high resistance to biodegradation: Implication for molecular anti-melanoma immunotherapy, J IMMUNOL, 167(10), 2001, pp. 5852-5861
Authors:
Miconnet, I
Coste, I
Beermann, F
Haeuw, JF
Cerottini, JC
Bonnefoy, JY
Romero, P
Renno, T
Citation: I. Miconnet et al., Cancer vaccine design: A novel bacterial adjuvant for peptide-specific CTLinduction, J IMMUNOL, 166(7), 2001, pp. 4612-4619
Authors:
Pittet, MJ
Zippelius, A
Speiser, DE
Assenmacher, M
Guillaume, P
Valmori, D
Lienard, D
Lejeune, F
Cerottini, JC
Romero, P
Citation: Mj. Pittet et al., Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: Implicationsof a novel approach for T cell monitoring in infectious and malignant diseases, J IMMUNOL, 166(12), 2001, pp. 7634-7640
Authors:
Rimoldi, D
Muehlethaler, K
Salvi, S
Valmori, D
Romero, P
Cerottini, JC
Levy, F
Citation: D. Rimoldi et al., Subcellular localization of the melanoma-associated protein Melan-A(MART-1) influences the processing of its HLA-A2-restricted epitope, J BIOL CHEM, 276(46), 2001, pp. 43189-43196
Authors:
Ayyoub, M
Migliaccio, M
Guillaume, P
Lienard, D
Cerottini, JC
Romero, P
Levy, F
Speiser, DE
Valmori, D
Citation: M. Ayyoub et al., Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cellsfrom melanoma patients reveals inefficient antigen processing., EUR J IMMUN, 31(9), 2001, pp. 2642-2651
Authors:
Doucey, MA
Legler, DF
Boucheron, N
Cerottini, JC
Bron, C
Luescher, IF
Citation: Ma. Doucey et al., CTL activation is induced by cross-linking of TCR/MHC-peptide-CD8/p56(lck)adducts in rafts, EUR J IMMUN, 31(5), 2001, pp. 1561-1570
Authors:
Speiser, DE
Migliaccio, M
Pittet, MJ
Valmori, D
Lienard, D
Lejeune, F
Reichenbach, P
Guillaume, P
Luscher, I
Cerottini, JC
Romero, P
Citation: De. Speiser et al., Human CD8(+) T cells expressing HLA-DR and CD28 show telomerase activity and are distinct from cytolytic effector T cells, EUR J IMMUN, 31(2), 2001, pp. 459-466
Authors:
Dietrich, PY
Walker, PR
Quiquerez, AL
Perrin, G
Dutoit, V
Lienard, D
Guillaume, P
Cerottini, JC
Romero, P
Valmori, D
Citation: Py. Dietrich et al., Melanoma patients respond to a cytotoxic T lymphocyte-defined self-peptidewith diverse and nonoverlapping T-cell receptor repertoires, CANCER RES, 61(5), 2001, pp. 2047-2054
Authors:
Dutoit, V
Rubio-Godoy, V
Dietrich, PY
Quiqueres, AL
Schnuriger, V
Rimoldi, D
Lienard, D
Speiser, D
Guillaume, P
Batard, P
Cerottini, JC
Romero, P
Valmori, D
Citation: V. Dutoit et al., Heterogeneous T-cell response to MAGE-A10(254-262): High avidity-specific cytolytic T lymphocytes show superior antitumor activity, CANCER RES, 61(15), 2001, pp. 5850-5856
Authors:
Pinilla, C
Rubio-Godoy, V
Dutoit, V
Guillaume, P
Simon, R
Zhao, YD
Houghten, RA
Cerottini, JC
Romero, P
Valmori, D
Citation: C. Pinilla et al., Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes, CANCER RES, 61(13), 2001, pp. 5153-5160
Authors:
Jeannin, P
Renno, T
Goetsch, L
Miconnet, I
Aubry, JP
Delneste, Y
Herbault, N
Baussant, T
Magistrelli, G
Soulas, C
Romero, P
Cerottini, JC
Bonnefoy, JY
Citation: P. Jeannin et al., OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway, NAT IMMUNOL, 1(6), 2000, pp. 502-509
Authors:
Morel, S
Levy, F
Burlet-Schiltz, O
Brasseur, F
Probst-Kepper, M
Peitrequin, AL
Monsarrat, B
Van Velthoven, R
Cerottini, JC
Boon, T
Gairin, JE
Van den Eynde, BJ
Citation: S. Morel et al., Processing of some antigens by the standard proteasome but not by the immunoproteasome results in poor presentation by dendritic cells, IMMUNITY, 12(1), 2000, pp. 107-117
Authors:
Migliaccio, M
Amacker, M
Just, T
Reichenbach, P
Valmori, D
Cerottini, JC
Romero, P
Nabholz, M
Citation: M. Migliaccio et al., Ectopic human telomerase catalytic subunit expression maintains telomere length but is not sufficient for CD8(+) lymphocyte immortalization, J IMMUNOL, 165(9), 2000, pp. 4978-4984
Authors:
Rimoldi, D
Rubio-Godoy, V
Dutoit, V
Lienard, D
Salvi, S
Guillaume, P
Speiser, D
Stockert, E
Spagnoli, G
Servis, C
Cerottini, JC
Lejeune, F
Romero, P
Valmori, D
Citation: D. Rimoldi et al., Efficient simultaneous presentation of NY-ESO-1/LAGE-1 primary and nonprimary open reading frame-derived CTL epitopes in melanoma, J IMMUNOL, 165(12), 2000, pp. 7253-7261
Authors:
Valmori, D
Dutoit, V
Lienard, D
Lejeune, F
Speiser, D
Rimoldi, D
Cerundolo, V
Dietrich, PY
Cerottini, JC
Romero, P
Citation: D. Valmori et al., Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8(+) T cells in melanoma patients, J IMMUNOL, 165(1), 2000, pp. 533-538
Authors:
Pittet, MJ
Speiser, DE
Valmori, D
Cerottini, JC
Romero, P
Citation: Mj. Pittet et al., Cutting edge: Cytolytic effector function in human circulating CD8(+) T cells closely correlates with CD56 surface expression, J IMMUNOL, 164(3), 2000, pp. 1148-1152
Authors:
Valmori, D
Levy, F
Miconnet, I
Zajac, P
Spagnoli, GC
Rimoldi, D
Lienard, D
Cerundolo, V
Cerottini, JC
Romero, P
Citation: D. Valmori et al., Induction of potent antitumor CTL responses by recombinant vaccinia encoding a Melan-A peptide analogue, J IMMUNOL, 164(2), 2000, pp. 1125-1131